![Andrew Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Neill
Financieel Directeur/CFO bij
SHATTUCK LABS, INC.
Vermogen: 2 M $ op 30-06-2026
Profiel
Andrew R.
Neill is the founder of Lumos Pharma, Inc., founded in 2010.
Mr. Neill currently works at Shattuck Labs, Inc. as Chief Financial Officer since 2021.
Mr. Neill attended Texas Christian University for undergraduate education.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SHATTUCK LABS, INC. 0,32% | 12-05-2026 | 292.251 ( 0,32% ) | 2 M $ | 30-06-2026 |
Actieve functies van Andrew Neill
| Bedrijven | Functie | Begin |
|---|---|---|
| SHATTUCK LABS, INC. | Financieel Directeur/CFO | 16-03-2021 |
Eerdere bekende functies van Andrew Neill
| Bedrijven | Functie | Einde |
|---|---|---|
| LUMOS PHARMA, INC. | Oprichter | 01-08-2016 |
Opleiding van Andrew Neill
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
